Oxford Biomedica launches the TetraVecta™ System
Oxford Biomedica launches the TetraVectaTM – the next generation lentiviral vector system Oxford, UK – 15 May 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a quality and innovation-led viral…